E-Home Household Service Holdings Ltd EJH Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001213900-25-045434
cik 1769768
name E-HOME HOUSEHOLD SERVICE HOLDINGS LTD
sic 7600
countryba CN
stprba
cityba CANGSHAN DISTRICT, FUZHOU CITY
zipba 350001
bas1 FLOOR 9, BUILDING 14, HAIXIBAIYUE TOWN
bas2 HEYUAN ROAD, LUZHOU TOWN
baph 86-591-87590668
countryma CN
stprma
cityma CANGSHAN DISTRICT, FUZHOU CITY
zipma 350001
mas1 FLOOR 9, BUILDING 14, HAIXIBAIYUE TOWN
mas2 HEYUAN ROAD, LUZHOU TOWN
countryinc KY
stprinc
ein 000000000
former
changed
afs 4-NON
wksi 0
fye 0630
form 6-K
period 20241231
fy 2024
fp Q2
filed 20250519
accepted 2025-05-19 16:30:00.0
prevrpt 0
detail 0
instance ea0239579-6k_ehome_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001213900-25-045434 20240630 Liabilities 15561047.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Deferred Income Tax Liabilities Net 1819826.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Accounts Payable And Accrued Liabilities Current 7281276.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Accounts Payable And Accrued Liabilities Current 6858696.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -8024380.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Amortization Of Financing Costs 623801.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Cash And Cash Equivalents At Carrying Value 132240950.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Contract With Customer Liability Current 501890.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Cost Of Revenue 11201726.0000 USD 2 us-gaap/2024 Product Or Service= Maintenance;
0001213900-25-045434 20231231 Earnings Per Share Basic -19.6200 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Earnings Per Share Basic -0.9500 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -765098.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Equity Incentive Plan 327340.0000 USD 2 0001213900-25-045434
0001213900-25-045434 20231231 Income Tax Expense Benefit USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Contract With Customer Liability -628531.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Other Noncurrent Assets -2014298.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets -4143426.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Prepaid Supplies -944315.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Investment Income Interest 127142.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Investment Income Interest 178181.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Liabilities Current 12427945.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Net Cash Provided By Used In Investing Activities -10688160.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Net Cash Provided By Used In Operating Activities 1381424.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Net Income Loss Attributable To Noncontrolling Interest 23601.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Net Income Loss Attributable To Noncontrolling Interest USD 2 us-gaap/2024
0001213900-25-045434 20241231 Operating Income Loss -5224774.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -5949.0000 USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -856181.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Payments To Acquire Loans Receivable 31930000.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Proceeds From Issuance Of Common Stock 12001420.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Proceeds From Repayments Of Related Party Debt 20662.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Property Plant And Equipment Net 4128751.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Revenue From Contract With Customer Including Assessed Tax 7836579.0000 USD 2 us-gaap/2024 Product Or Service= Housekeeping;
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 664100.0000 USD 0 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 307.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 664100.0000 USD 0 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20231231 Stock Issued During Period Shares Conversion Of Convertible Securities 33490.0000 shares 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities 3480679.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity 5731103.0000 USD 2 0001213900-25-045434
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity 6546925.0000 USD 2 0001213900-25-045434 Equity Components= Retained Earnings;
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues 9855079.0000 USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split -146.0000 USD 2 0001213900-25-045434 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20241231 Weighted Average Number Of Diluted Shares Outstanding 8402293.0000 shares 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Other Noncurrent Assets -350833.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Accounts Receivable Net Current 464416.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Accumulated Other Comprehensive Income Loss Net Of Tax -7168199.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Common Stock Shares Outstanding 8690171.0000 shares 0 us-gaap/2024
0001213900-25-045434 20231231 Cost Of Revenue 20371994.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Cost Of Revenue 1719011.0000 USD 2 us-gaap/2024 Product Or Service= Senior Care Services;
0001213900-25-045434 20241231 Cost Of Revenue 12510940.0000 USD 2 us-gaap/2024 Product Or Service= Maintenance;
0001213900-25-045434 20241231 Finite Lived Intangible Assets Net 831.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 General And Administrative Expense 2786747.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Gross Profit 6575189.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Income Taxes Paid USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Accounts Payable And Accrued Liabilities -1171817.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Issuance Of Shares To Directors And Consultants 327340.0000 USD 2 0001213900-25-045434
0001213900-25-045434 20240630 Liabilities Noncurrent 3133102.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Operating Lease Liability Current 77193.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Operating Lease Liability Noncurrent 1313276.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 687989.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20241231 Proceeds From Issuance Of Common Stock 65000257.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Profit Loss -5169892.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Repayments Of Convertible Debt USD 2 us-gaap/2024
0001213900-25-045434 20241231 Revenue From Contract With Customer Including Assessed Tax 26372068.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 162814934.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 191883857.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity USD 2 0001213900-25-045434 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues 6500.0000 USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split 146.0000 USD 2 0001213900-25-045434 Equity Components= Common Stock;
0001213900-25-045434 20241231 Supplies 25319.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Weighted Average Number Of Shares Outstanding Basic 263473.0000 shares 2 us-gaap/2024
0001213900-25-045434 20241231 Weighted Average Number Of Shares Outstanding Basic 8402287.0000 shares 2 us-gaap/2024
0001213900-25-045434 20240630 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 100665223.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 132310506.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Common Stock Shares Outstanding 2044363.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Depreciation Depletion And Amortization 237631.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Depreciation Depletion And Amortization 143348.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Due From Related Partie USD 2 0001213900-25-045434
0001213900-25-045434 20240630 Finite Lived Intangible Assets Net 2377.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Gain Loss On Investments USD 2 us-gaap/2024
0001213900-25-045434 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -5193493.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Minority Interest 795869.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Minority Interest -19953.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Net Cash Provided By Used In Financing Activities 11822082.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Net Cash Provided By Used In Financing Activities 64662822.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Net Cash Provided By Used In Operating Activities -322441.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Net Income Loss -7945649.0000 USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20231231 Nonoperating Income Expense -881909.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Notes And Loans Receivable Net Current USD 0 us-gaap/2024
0001213900-25-045434 20231231 Operating Expenses 10886773.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Operating Lease Liability Current 76419.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Operating Lease Liability Noncurrent 1300195.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20240630 Prepaid Expense And Other Assets Noncurrent 60769864.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Revenue From Contract With Customer Including Assessed Tax 16896126.0000 USD 2 us-gaap/2024 Product Or Service= Maintenance;
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -7109254.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -3632766.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 664100.0000 USD 0 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 256877468.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20241231 Stock Issued During Period Value Of Disposal 5731103.0000 USD 2 0001213900-25-045434
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split USD 2 0001213900-25-045434 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20241231 Taxes Payable Current 31871.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Assets Current 108769546.0000 USD 0 us-gaap/2024
0001213900-25-045434 20230630 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 71252380.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 74325312.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Common Stock Shares Outstanding 2044363.0000 shares 0 us-gaap/2024
0001213900-25-045434 20241231 Common Stock Shares Outstanding 8690171.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Common Stock Value 8690.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Comprehensive Income Net Of Tax -4505504.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Cost Of Revenue 700536.0000 USD 2 us-gaap/2024 Product Or Service= Educational Consulting Services;
0001213900-25-045434 20231231 Cost Of Revenue 43241.0000 USD 2 us-gaap/2024 Product Or Service= Sales Of Pharmaceutical Products;
0001213900-25-045434 20241231 Cost Of Revenue 20512460.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Cost Of Revenue 7276240.0000 USD 2 us-gaap/2024 Product Or Service= Housekeeping;
0001213900-25-045434 20241231 Cost Of Revenue 9896.0000 USD 2 us-gaap/2024 Product Or Service= Sales Of Pharmaceutical Products;
0001213900-25-045434 20241231 Equity Incentive Plan USD 2 0001213900-25-045434
0001213900-25-045434 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -7945649.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Income Tax Expense Benefit USD 2 us-gaap/2024
0001213900-25-045434 20241231 Inventory Net USD 0 us-gaap/2024
0001213900-25-045434 20241231 Liabilities Noncurrent 1697618.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Net Cash Provided By Used In Investing Activities -31930000.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Net Income Loss -5169892.0000 USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Net Income Loss -7945649.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Operating Lease Right Of Use Asset Amortization Expense 201952.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -856181.0000 USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20240630 Other Liabilities Current 3154698.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001213900-25-045434 20241231 Other Liabilities Current 1810037.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001213900-25-045434 20241231 Prepaid Expense And Other Assets Noncurrent 60353162.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Profit Loss -7945649.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Retained Earnings Accumulated Deficit -24418619.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Revenue From Contract With Customer Including Assessed Tax 957574.0000 USD 2 us-gaap/2024 Product Or Service= Educational Consulting Services;
0001213900-25-045434 20231231 Revenue From Contract With Customer Including Assessed Tax 15151510.0000 USD 2 us-gaap/2024 Product Or Service= Maintenance;
0001213900-25-045434 20241231 Revenue From Contract With Customer Including Assessed Tax 8609890.0000 USD 2 us-gaap/2024 Product Or Service= Housekeeping;
0001213900-25-045434 20231231 Selling And Marketing Expense 8100026.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Selling And Marketing Expense 8759104.0000 USD 2 us-gaap/2024
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 137808606.0000 USD 0 us-gaap/2024
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 147005748.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 54.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 149112541.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -6415316.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8802658.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 163157776.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2044.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Retrospectively restated for effect of reverse stock splits on September 25, 2023, February 14, 2024 and September 24, 2024, and capital reduction on March 6, 2025.
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split USD 2 0001213900-25-045434 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Assets Current 167019611.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Assets Noncurrent 69042169.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2024
0001213900-25-045434 20240630 Common Stock Shares Issued 2044363.0000 shares 0 us-gaap/2024 Retrospectively restated for effect of reverse stock split on September 24, 2024 and capital reduction on March 6, 2025.
0001213900-25-045434 20231231 Due From Related Partie -10688160.0000 USD 2 0001213900-25-045434
0001213900-25-045434 20231231 Earnings Per Share Diluted -19.6200 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Accounts Payable And Accrued Liabilities -684230.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Accrued Income Taxes Payable -6426.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Inventories -18753.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Investment Income Investment Expense 11509.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Liabilities And Stockholders Equity 178718823.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Net Income Loss -5193493.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Net Income Loss -23601.0000 USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20241231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20231231 Payments To Acquire Loans Receivable USD 2 us-gaap/2024
0001213900-25-045434 20241231 Restricted Cash Current 69556.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Retained Earnings Accumulated Deficit -23019895.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Revenue From Contract With Customer Including Assessed Tax 190297.0000 USD 2 us-gaap/2024 Product Or Service= Sales Of Pharmaceutical Products;
0001213900-25-045434 20240630 Statutory Accounting Practices Statutory Capital And Surplus Balance 664100.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 851174.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -7168199.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity USD 2 0001213900-25-045434 Equity Components= Common Stock;
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity USD 2 0001213900-25-045434 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split USD 2 0001213900-25-045434
0001213900-25-045434 20240630 Taxes Payable Current 38571.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Inventories -22374.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Accounts Receivable Net Current 17931.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Additional Paid In Capital Common Stock 191883857.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Amortization Of Financing Costs USD 2 us-gaap/2024
0001213900-25-045434 20241231 Asset Retirement Obligation Accretion Expense USD 2 us-gaap/2024
0001213900-25-045434 20240630 Assets 178718823.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Cash And Cash Equivalents At Carrying Value 100665223.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Contract With Customer Liability Current 499059.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Cost Of Revenue 143370.0000 USD 2 us-gaap/2024 Product Or Service= Senior Care Services;
0001213900-25-045434 20241231 Earnings Per Share Diluted -0.9500 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Income Taxes Paid USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Accounts Receivable -353314.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Contract With Customer Liability 1483.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Operating Lease Liability -99753.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Operating Lease Liability -5891.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -3320800.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Prepaid Supplies -11282.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Interest Paid Net 11509.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Investment Income Investment Expense 385524.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Issuance Of Shares To Directors And Consultants USD 2 0001213900-25-045434
0001213900-25-045434 20241231 Liabilities And Stockholders Equity 236061780.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Liabilities Current 9276856.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Nonoperating Income Expense -2720875.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Notes And Loans Receivable Net Current 31930000.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Other Nonoperating Income Expense -2887547.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Restricted Cash Current 144855.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Revenue From Contract With Customer Including Assessed Tax 2811223.0000 USD 2 us-gaap/2024 Product Or Service= Senior Care Services;
0001213900-25-045434 20241231 Revenue From Contract With Customer Including Assessed Tax 502957.0000 USD 2 us-gaap/2024 Product Or Service= Educational Consulting Services;
0001213900-25-045434 20241231 Revenue From Contract With Customer Including Assessed Tax 8407.0000 USD 2 us-gaap/2024 Product Or Service= Sales Of Pharmaceutical Products;
0001213900-25-045434 20241231 Revenue From Contract With Customer Including Assessed Tax 354688.0000 USD 2 us-gaap/2024 Product Or Service= Senior Care Services;
0001213900-25-045434 20240630 Short Term Borrowings 1375091.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Statutory Accounting Practices Statutory Capital And Surplus Balance 664100.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Stockholders Equity 162361907.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Stockholders Equity 225107259.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 225087306.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Stock Issued1 3480679.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Stock Issued During Period Shares Employee Benefit Plan 5200.0000 shares 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Stock Issued During Period Shares New Issues 214634.0000 shares 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity -815822.0000 USD 2 0001213900-25-045434 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues 2146341.0000 USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues 64993757.0000 USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20231231 Stock Issued During Period Value Of Disposal USD 2 0001213900-25-045434
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split USD 2 0001213900-25-045434 Equity Components= Statutory Reserve;
0001213900-25-045434 20231231 Interest Paid Net 385524.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Inventory Net 18751.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Assets 236061780.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Assets Noncurrent 69949277.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 2515346.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-045434 20241231 Common Stock Shares Issued 8690171.0000 shares 0 us-gaap/2024
0001213900-25-045434 20240630 Common Stock Value 2044.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Cost Of Revenue 6707480.0000 USD 2 us-gaap/2024 Product Or Service= Housekeeping;
0001213900-25-045434 20231231 Gain Loss On Sale Of Property Plant Equipment -60910.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 General And Administrative Expense 2325278.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Gross Profit 5859608.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Accounts Receivable -339061.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Increase Decrease In Accrued Income Taxes Payable 5208.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20231231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20241231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Net Income Loss USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20241231 Operating Expenses 11084382.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Operating Lease Right Of Use Asset 4795273.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Operating Lease Right Of Use Asset 4559425.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 693938.0000 USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Prepaid Expense And Other Assets Current 2735855.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Proceeds From Repayments Of Related Party Debt -337435.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Provision For Other Credit Losses USD 2 us-gaap/2024
0001213900-25-045434 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 880724.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 664100.0000 USD 0 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8024380.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20241231 Stock Issued1 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Stock Issued During Period Shares Reverse Stock Splits 145808.0000 shares 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities 3145779.0000 USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities 334900.0000 USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities USD 2 us-gaap/2024 Equity Components= Statutory Reserve;
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan 275340.0000 USD 2 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan 52000.0000 USD 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20240630 Supplies 969733.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Additional Paid In Capital Common Stock 256877468.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Asset Retirement Obligation Accretion Expense 623801.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 32410381.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-045434 20240630 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2024
0001213900-25-045434 20230630 Common Stock Shares Outstanding 54498.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Common Stock Shares Outstanding 307822.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Comprehensive Income Net Of Tax -8801830.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Cost Of Revenue 572014.0000 USD 2 us-gaap/2024 Product Or Service= Educational Consulting Services;
0001213900-25-045434 20241231 Deferred Income Tax Liabilities Net 397423.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 557586.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Gain Loss On Investments -2880376.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Gain Loss On Sale Of Property Plant Equipment USD 2 us-gaap/2024
0001213900-25-045434 20241231 Liabilities 10974474.0000 USD 0 us-gaap/2024
0001213900-25-045434 20231231 Operating Income Loss -4311584.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Operating Lease Right Of Use Asset Amortization Expense 304163.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20231231 Other Nonoperating Income Expense 274.0000 USD 2 us-gaap/2024
0001213900-25-045434 20240630 Prepaid Expense And Other Assets Current 6506568.0000 USD 0 us-gaap/2024
0001213900-25-045434 20240630 Property Plant And Equipment Net 4381763.0000 USD 0 us-gaap/2024
0001213900-25-045434 20241231 Provision For Other Credit Losses 93072.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Repayments Of Convertible Debt 200000.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Revenue From Contract With Customer Including Assessed Tax 26947183.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Short Term Borrowings USD 0 us-gaap/2024
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 795869.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -23019895.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 8690.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -19953.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001213900-25-045434 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -24418619.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Stock Issued During Period Shares New Issues 6500000.0000 shares 2 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045434 20231231 Stock Issued During Period Value Conversion Of Convertible Securities USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Stock Issued During Period Value Disposal Of Equity USD 2 0001213900-25-045434 Equity Components= Additional Paid In Capital;
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan 327340.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Stock Issued During Period Value Employee Benefit Plan USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues 12001420.0000 USD 2 us-gaap/2024
0001213900-25-045434 20231231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues 65000257.0000 USD 2 us-gaap/2024
0001213900-25-045434 20241231 Stock Issued During Period Value New Issues USD 2 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045434 20241231 Stock Issued During Period Value Reverse Stock Split USD 2 0001213900-25-045434 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-045434 20231231 Weighted Average Number Of Diluted Shares Outstanding 263479.0000 shares 2 us-gaap/2024 Retrospectively restated for effect of reverse stock split on February 14, 2024 and September 24, 2024.

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Other Noncurrent Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Accounts Payable And Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Supplies us-gaap/2024 0 0 monetary I D Prepaid Supplies Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
Taxes Payable Current us-gaap/2024 0 0 monetary I C Taxes Payable, Current Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Gain Loss On Investments us-gaap/2024 0 0 monetary D C Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Increase Decrease In Contract With Customer Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Contract with Customer, Liability Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Repayments Of Convertible Debt us-gaap/2024 0 0 monetary D C Repayments of Convertible Debt The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued1 us-gaap/2024 0 0 monetary D C Stock Issued The fair value of stock issued in noncash financing activities.
Due From Related Partie 0001213900-25-045434 1 0 monetary D D Due From Related Partie Represent the amount of due from related parties.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Provision For Other Credit Losses us-gaap/2024 0 0 monetary D D Provision for Other Credit Losses Amount of expense related to credit loss from transactions other than loan and lease transactions.
Restricted Cash Current us-gaap/2024 0 0 monetary I D Restricted Cash, Current Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Income Taxes Paid us-gaap/2024 0 0 monetary D C Income Taxes Paid Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Cost Of Revenue us-gaap/2024 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Selling And Marketing Expense us-gaap/2024 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities.
Stock Issued During Period Shares Reverse Stock Splits us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Reverse Stock Splits Reduction in the number of shares during the period as a result of a reverse stock split.
Issuance Of Shares To Directors And Consultants 0001213900-25-045434 1 0 monetary D C Issuance Of Shares To Directors And Consultants Issue of shares to directors and consultants for consideartion other than cash.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Income Taxes Payable The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Prepaid Expense And Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Noncurrent Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.
Stock Issued During Period Shares Employee Benefit Plan us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Employee Benefit Plan Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.
Finite Lived Intangible Assets Net us-gaap/2024 0 0 monetary I D Finite-Lived Intangible Assets, Net Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Increase Decrease In Prepaid Supplies us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Supplies Amount of increase (decrease) of consideration paid in advance for supplies that provide economic benefits in future periods.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Liabilities Current us-gaap/2024 0 0 monetary I C Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Statutory Accounting Practices Statutory Capital And Surplus Balance us-gaap/2024 0 0 monetary I C Statutory Accounting Practices, Statutory Capital and Surplus, Balance The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.
Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Short Term Borrowings us-gaap/2024 0 0 monetary I C Short-Term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
Proceeds From Repayments Of Related Party Debt us-gaap/2024 0 0 monetary D D Proceeds from (Repayments of) Related Party Debt Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.
Stock Issued During Period Value Reverse Stock Split 0001213900-25-045434 1 0 monetary D C Stock Issued During Period Value Reverse Stock Split Represents the value of stock issued under reverse stock split.
Amortization Of Financing Costs us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Equity Incentive Plan 0001213900-25-045434 1 0 monetary D D Equity Incentive Plan Represent the amount of equity incentive plan.
Stock Issued During Period Value Of Disposal 0001213900-25-045434 1 0 monetary D C Stock Issued During Period Value Of Disposal The amount of disposal of ownership in fuzhou fumao.
Assets Noncurrent us-gaap/2024 0 0 monetary I D Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 0 0 monetary D D Operating Lease, Right-of-Use Asset, Periodic Reduction Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.
Asset Retirement Obligation Accretion Expense us-gaap/2024 0 0 monetary D D Asset Retirement Obligation, Accretion Expense Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.
Contract With Customer Liability Current us-gaap/2024 0 0 monetary I C Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Investment Income Investment Expense us-gaap/2024 0 0 monetary D D Investment Income, Investment Expense Amount of expenses related to the generation of investment income.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Revenue From Contract With Customer Including Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Including Assessed Tax Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Minority Interest us-gaap/2024 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Stock Issued During Period Value Disposal Of Equity 0001213900-25-045434 1 0 monetary D C Stock Issued During Period Value Disposal Of Equity Represents the value of stock issued under disposal of equity.
Notes And Loans Receivable Net Current us-gaap/2024 0 0 monetary I D Financing Receivable, after Allowance for Credit Loss, Current Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Payments To Acquire Loans Receivable us-gaap/2024 0 0 monetary D C Payments to Acquire Loans Receivable The cash outflow for the purchase of loan receivable arising from the financing of goods and services.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Stock Issued During Period Value Employee Benefit Plan us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Employee Benefit Plan Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001213900-25-045434 2 7 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001213900-25-045434 2 8 BS 0 H Restricted Cash Current us-gaap/2024 Restricted cash 0
0001213900-25-045434 2 9 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable 0
0001213900-25-045434 2 10 BS 0 H Supplies us-gaap/2024 Advances to suppliers 0
0001213900-25-045434 2 11 BS 0 H Inventory Net us-gaap/2024 Inventories 0
0001213900-25-045434 2 12 BS 0 H Notes And Loans Receivable Net Current us-gaap/2024 Loan receivable 0
0001213900-25-045434 2 13 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepayment, receivables and other current assets 0
0001213900-25-045434 2 14 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001213900-25-045434 2 16 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment, net 0
0001213900-25-045434 2 17 BS 0 H Finite Lived Intangible Assets Net us-gaap/2024 Intangible assets, net 0
0001213900-25-045434 2 18 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease - right-of-use assets, net 0
0001213900-25-045434 2 19 BS 0 H Prepaid Expense And Other Assets Noncurrent us-gaap/2024 Long-term deposits and other non-current assets 0
0001213900-25-045434 2 20 BS 0 H Assets Noncurrent us-gaap/2024 Total non-current assets 0
0001213900-25-045434 2 21 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001213900-25-045434 2 23 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0001213900-25-045434 2 24 BS 0 H Contract With Customer Liability Current us-gaap/2024 Advances from customers 0
0001213900-25-045434 2 25 BS 0 H Taxes Payable Current us-gaap/2024 Taxes payable 0
0001213900-25-045434 2 26 BS 0 H Operating Lease Liability Current us-gaap/2024 Current maturities of operating lease liabilities 0
0001213900-25-045434 2 27 BS 0 H Other Liabilities Current us-gaap/2024 Due to related parties 0
0001213900-25-045434 2 28 BS 0 H Short Term Borrowings us-gaap/2024 Short-term loan 0
0001213900-25-045434 2 29 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001213900-25-045434 2 31 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Long-term portion of operating lease liabilities 0
0001213900-25-045434 2 32 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred tax liabilities, net 0
0001213900-25-045434 2 33 BS 0 H Liabilities Noncurrent us-gaap/2024 Total non-current liabilities 0
0001213900-25-045434 2 34 BS 0 H Liabilities us-gaap/2024 TOTAL LIABILITIES 0
0001213900-25-045434 2 35 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 18) 0
0001213900-25-045434 2 37 BS 0 H Common Stock Value us-gaap/2024 Ordinary shares, $0.001 par value, 100,000,000 shares authorized; 8,690,171 shares and 2,044,363 issued and outstanding as of December 31, 2024 and June 30, 2024) 0
0001213900-25-045434 2 38 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0001213900-25-045434 2 39 BS 0 H Statutory Accounting Practices Statutory Capital And Surplus Balance us-gaap/2024 Statutory reserve 0
0001213900-25-045434 2 40 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulate deficits 0
0001213900-25-045434 2 41 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0001213900-25-045434 2 42 BS 0 H Stockholders Equity us-gaap/2024 Total equity attributable to shareholders 0
0001213900-25-045434 2 43 BS 0 H Minority Interest us-gaap/2024 Non-controlling interest 0
0001213900-25-045434 2 44 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 TOTAL SHAREHOLDERS EQUITY 0
0001213900-25-045434 2 45 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY 0
0001213900-25-045434 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Ordinary shares, par value (in Dollars per share) 0
0001213900-25-045434 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Ordinary shares, shares authorized 0
0001213900-25-045434 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Ordinary shares, shares issued 0
0001213900-25-045434 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Ordinary shares, shares outstanding 0
0001213900-25-045434 4 11 IS 0 H Revenue From Contract With Customer Including Assessed Tax us-gaap/2024 Total revenues 0
0001213900-25-045434 4 13 IS 0 H Cost Of Revenue us-gaap/2024 Total cost of revenues 0
0001213900-25-045434 4 14 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0001213900-25-045434 4 16 IS 0 H Selling And Marketing Expense us-gaap/2024 Sales and marketing expenses 0
0001213900-25-045434 4 17 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative expenses 0
0001213900-25-045434 4 18 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001213900-25-045434 4 19 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0001213900-25-045434 4 21 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0001213900-25-045434 4 22 IS 0 H Investment Income Investment Expense us-gaap/2024 Interest expenses 1
0001213900-25-045434 4 23 IS 0 H Amortization Of Financing Costs us-gaap/2024 Amortization of financing cost 1
0001213900-25-045434 4 24 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other (expenses) income, net 0
0001213900-25-045434 4 25 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other expenses, net 0
0001213900-25-045434 4 26 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Loss before income taxes 0
0001213900-25-045434 4 27 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax expense 1
0001213900-25-045434 4 28 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045434 4 30 IS 0 H Profit Loss us-gaap/2024 Net loss attributable to the Companys shareholders 0
0001213900-25-045434 4 31 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Net loss attributable to non-controlling interests 1
0001213900-25-045434 4 32 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045434 4 34 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment, net of nil tax 0
0001213900-25-045434 4 35 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Total comprehensive loss 0
0001213900-25-045434 4 36 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per ordinary share - basic (in Dollars per share) 0
0001213900-25-045434 4 37 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per ordinary share - diluted (in Dollars per share) 0
0001213900-25-045434 4 38 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average number of ordinary shares outstanding - basic (in Shares) 0
0001213900-25-045434 4 39 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average number of ordinary shares outstanding - diluted (in Shares) 0
0001213900-25-045434 5 11 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance 0
0001213900-25-045434 5 12 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-045434 5 13 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045434 5 14 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0001213900-25-045434 5 15 EQ 0 H Stock Issued During Period Value Disposal Of Equity 0001213900-25-045434 Disposal of equity in Zhongrun 0
0001213900-25-045434 5 16 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Shares issued to investors 0
0001213900-25-045434 5 17 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Shares issued to investors (in Shares) 0
0001213900-25-045434 5 18 EQ 0 H Stock Issued During Period Value Reverse Stock Split 0001213900-25-045434 Reverse stock split 0
0001213900-25-045434 5 19 EQ 0 H Stock Issued During Period Shares Reverse Stock Splits us-gaap/2024 Reverse stock split (in Shares) 0
0001213900-25-045434 5 20 EQ 0 H Stock Issued During Period Value Employee Benefit Plan us-gaap/2024 Shares issued under equity incentive plan 0
0001213900-25-045434 5 21 EQ 0 H Stock Issued During Period Shares Employee Benefit Plan us-gaap/2024 Shares issued under equity incentive plan (in Shares) 0
0001213900-25-045434 5 22 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Shares issued for conversion of convertible notes 0
0001213900-25-045434 5 23 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 Shares issued for conversion of convertible notes (in Shares) 0
0001213900-25-045434 5 24 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance 0
0001213900-25-045434 5 25 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-045434 6 2 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045434 6 3 CF 0 H Investment Income Investment Expense us-gaap/2024 Interest expense 0
0001213900-25-045434 6 4 CF 0 H Provision For Other Credit Losses us-gaap/2024 Estimated credit loss 0
0001213900-25-045434 6 5 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001213900-25-045434 6 6 CF 0 H Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 Amortization of right-of-use assets 0
0001213900-25-045434 6 7 CF 0 H Asset Retirement Obligation Accretion Expense us-gaap/2024 Convertible note - Amortization of financing cost 0
0001213900-25-045434 6 8 CF 0 H Equity Incentive Plan 0001213900-25-045434 Equity incentive plan 0
0001213900-25-045434 6 9 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 Written off of property, plant and equipment 1
0001213900-25-045434 6 10 CF 0 H Gain Loss On Investments us-gaap/2024 Investment loss from disposal of equity in Zhongrun 1
0001213900-25-045434 6 12 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivables 1
0001213900-25-045434 6 13 CF 0 H Increase Decrease In Prepaid Supplies us-gaap/2024 Advance to suppliers 1
0001213900-25-045434 6 14 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0001213900-25-045434 6 15 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepayment, receivables and other current assets 1
0001213900-25-045434 6 16 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Long-term deposits and other non-current assets 1
0001213900-25-045434 6 17 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0001213900-25-045434 6 18 CF 0 H Increase Decrease In Contract With Customer Liability us-gaap/2024 Advance from customers 0
0001213900-25-045434 6 19 CF 0 H Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 Taxes payable 0
0001213900-25-045434 6 20 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Operating lease liabilities 0
0001213900-25-045434 6 21 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash (used in) provided by operating activities 0
0001213900-25-045434 6 23 CF 0 H Payments To Acquire Loans Receivable us-gaap/2024 Loan receivable 1
0001213900-25-045434 6 24 CF 0 H Due From Related Partie 0001213900-25-045434 Due from related parties 0
0001213900-25-045434 6 25 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001213900-25-045434 6 27 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from share issuance 0
0001213900-25-045434 6 28 CF 0 H Repayments Of Convertible Debt us-gaap/2024 Repayment convertible note 1
0001213900-25-045434 6 29 CF 0 H Proceeds From Repayments Of Related Party Debt us-gaap/2024 (Payment to) Collection from related parties 0
0001213900-25-045434 6 30 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001213900-25-045434 6 31 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Net increase in cash and cash equivalents 0
0001213900-25-045434 6 32 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effects of currency translation 0
0001213900-25-045434 6 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001213900-25-045434 6 34 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001213900-25-045434 6 36 CF 0 H Income Taxes Paid us-gaap/2024 Income taxes paid 0
0001213900-25-045434 6 37 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001213900-25-045434 6 39 CF 0 H Stock Issued During Period Value Of Disposal 0001213900-25-045434 Disposal of equity in Zhongrun 0
0001213900-25-045434 6 40 CF 0 H Stock Issued1 us-gaap/2024 Issuance of shares for convertible note principal and interest settlement 0
0001213900-25-045434 6 41 CF 0 H Issuance Of Shares To Directors And Consultants 0001213900-25-045434 Issuance of shares to directors and consultants 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.